Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 396

1.

Engineering Iron-Nickel Nanoparticles for Magnetically-Induced CO2 Methanation in Continuous Flow.

De Masi D, Asensio JM, Fazzini PF, Lacroix LM, Chaudret B.

Angew Chem Int Ed Engl. 2020 Jan 23. doi: 10.1002/anie.201913865. [Epub ahead of print]

PMID:
31972063
2.

Nanoparticle Ripening : A Versatile Approach for the Size and Shape Control of Metallic Iron Nanoparticles.

Lacroix LM, Meffre A, Gatel C, Fazzini PF, Lachaize S, Respaud M, Chaudret B.

Chempluschem. 2019 Mar;84(3):302-306. doi: 10.1002/cplu.201800665.

PMID:
31950761
3.

B cells are associated with survival and immunotherapy response in sarcoma.

Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautès-Fridman C, Tawbi HA, Fridman WH.

Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.

PMID:
31942077
4.

Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression.

Aldea M, Hendriks L, Mezquita L, Jovelet C, Planchard D, Auclin E, Remon J, Howarth K, Benitez JC, Gazzah A, Lavaud P, Naltet C, Lacroix L, de Kievit F, Morris C, Green E, Ngo-Camus M, Rouleau E, Massard C, Caramella C, Friboulet L, Besse B.

J Thorac Oncol. 2019 Dec 13. pii: S1556-0864(19)33716-5. doi: 10.1016/j.jtho.2019.11.024. [Epub ahead of print]

PMID:
31843682
5.

Correlates of HIV Transmission Behaviors and HIV Testing in Predominately African American/Black Women with High-Risk Male Sex Partners.

Jones R, Hoover DR, Lacroix LJ, Garvey CM.

AIDS Behav. 2019 Dec 13. doi: 10.1007/s10461-019-02762-8. [Epub ahead of print]

PMID:
31834541
6.

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Laurent C, Nicolae A, Laurent C, Le Bras F, Haioun C, Fataccioli V, Amara N, Adélaïde J, Guille A, Schiano JM, Tesson B, Traverse-Glehen A, Chenard MP, Mescam L, Moreau A, Chassagne-Clement C, Somja J, Escudié F, André M, Martin N, Lacroix L, Lemonnier F, Hamy AS, Reyal F, Bannier M, Oberic L, Prade N, Frénois FX, Beldi-Ferchiou A, Delfau-Larue MH, Bouabdallah R, Birnbaum D, Brousset P, Xerri L, Gaulard P.

Blood. 2020 Jan 30;135(5):360-370. doi: 10.1182/blood.2019001904.

PMID:
31774495
7.

Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile.

Ward SE, Harries MH, Aldegheri L, Bradford AM, Ballini E, Dawson L, Lacroix L, Pardoe J, Starr K, Weil A, Waters K, Atack JR, Woolley M.

J Psychopharmacol. 2020 Jan;34(1):93-102. doi: 10.1177/0269881119872198. Epub 2019 Nov 26.

PMID:
31766938
8.

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies.

Carene D, Tran-Dien A, Lemonnier J, Dalenc F, Levy C, Pierga JY, Jacot W, Canon JL, Richon C, Lacroix L, Caux C, André F, Michiels S.

Breast Cancer Res Treat. 2020 Jan;179(2):387-401. doi: 10.1007/s10549-019-05462-y. Epub 2019 Oct 16.

PMID:
31620934
9.

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.

Recondo G, Mezquita L, Facchinetti F, Planchard D, Gazzah A, Bigot L, Rizvi AZ, Frias RL, Thiery JP, Scoazec JY, Sourisseau T, Howarth K, Deas O, Samofalova D, Galissant J, Tesson P, Braye F, Naltet C, Lavaud P, Mahjoubi L, Abou Lovergne A, Vassal G, Bahleda R, Hollebecque A, Nicotra C, Ngo-Camus M, Michiels S, Lacroix L, Richon C, Auger N, De Baere T, Tselikas L, Solary E, Angevin E, Eggermont AM, Andre F, Massard C, Olaussen KA, Soria JC, Besse B, Friboulet L.

Clin Cancer Res. 2020 Jan 1;26(1):242-255. doi: 10.1158/1078-0432.CCR-19-1104. Epub 2019 Oct 4.

PMID:
31585938
10.

Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial.

Di Giacomo AM, Covre A, Finotello F, Rieder D, Danielli R, Sigalotti L, Giannarelli D, Petitprez F, Lacroix L, Valente M, Cutaia O, Fazio C, Amato G, Lazzeri A, Monterisi S, Miracco C, Coral S, Anichini A, Bock C, Nemc A, Oganesian A, Lowder J, Azab M, Fridman WH, Sautès-Fridman C, Trajanoski Z, Maio M.

Clin Cancer Res. 2019 Dec 15;25(24):7351-7362. doi: 10.1158/1078-0432.CCR-19-1335. Epub 2019 Sep 17.

PMID:
31530631
11.

Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer.

Pailler E, Faugeroux V, Oulhen M, Mezquita L, Laporte M, Honoré A, Lecluse Y, Queffelec P, NgoCamus M, Nicotra C, Remon J, Lacroix L, Planchard D, Friboulet L, Besse B, Farace F.

Clin Cancer Res. 2019 Nov 15;25(22):6671-6682. doi: 10.1158/1078-0432.CCR-19-1176. Epub 2019 Aug 22.

PMID:
31439588
12.

Involvement of G-quadruplex regions in mammalian replication origin activity.

Prorok P, Artufel M, Aze A, Coulombe P, Peiffer I, Lacroix L, Guédin A, Mergny JL, Damaschke J, Schepers A, Ballester B, Méchali M.

Nat Commun. 2019 Jul 22;10(1):3274. doi: 10.1038/s41467-019-11104-0.

13.

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.

Roumenina LT, Daugan MV, Noé R, Petitprez F, Vano YA, Sanchez-Salas R, Becht E, Meilleroux J, Clec'h BL, Giraldo NA, Merle NS, Sun CM, Verkarre V, Validire P, Selves J, Lacroix L, Delfour O, Vandenberghe I, Thuilliez C, Keddani S, Sakhi IB, Barret E, Ferré P, Corvaïa N, Passioukov A, Chetaille E, Botto M, de Reynies A, Oudard SM, Mejean A, Cathelineau X, Sautès-Fridman C, Fridman WH.

Cancer Immunol Res. 2019 Jul;7(7):1091-1105. doi: 10.1158/2326-6066.CIR-18-0891. Epub 2019 Jun 4.

14.

Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases.

Flippot R, Biondani P, Auclin E, Xiao D, Hendriks L, Le Rhun E, Leduc C, Beau-Faller M, Gervais R, Remon J, Adam J, Planchard D, Lavaud P, Naltet C, Caramella C, Le Pechoux C, Lacroix L, Gazzah A, Mezquita L, Besse B.

J Thorac Oncol. 2019 Aug;14(8):1400-1407. doi: 10.1016/j.jtho.2019.05.007. Epub 2019 May 18.

PMID:
31108248
15.

Expert panel diagnosis demonstrated high reproducibility as reference standard in infectious diseases.

van Houten CB, Naaktgeboren CA, Ashkenazi-Hoffnung L, Ashkenazi S, Avis W, Chistyakov I, Corigliano T, Galetto A, Gangoiti I, Gervaix A, Glikman D, Ivaskeviciene I, Kuperman AA, Lacroix L, Loeffen Y, Luterbacher F, Meijssen CB, Mintegi S, Nasrallah B, Papan C, van Rossum AMC, Rudolph H, Stein M, Tal R, Tenenbaum T, Usonis V, de Waal W, Weichert S, Wildenbeest JG, de Winter-de Groot KM, Wolfs TFW, Mastboim N, Gottlieb TM, Cohen A, Oved K, Eden E, Feigin PD, Shani L, Bont LJ; IMPRIND consortium.

J Clin Epidemiol. 2019 Aug;112:20-27. doi: 10.1016/j.jclinepi.2019.03.010. Epub 2019 Mar 28.

PMID:
30930247
16.

Mapping and characterization of G-quadruplexes in the genome of the social amoeba Dictyostelium discoideum.

Saad M, Guédin A, Amor S, Bedrat A, Tourasse NJ, Fayyad-Kazan H, Pratviel G, Lacroix L, Mergny JL.

Nucleic Acids Res. 2019 May 21;47(9):4363-4374. doi: 10.1093/nar/gkz196.

17.

Redifferentiation of a BRAFK601E-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment.

Leboulleux S, Dupuy C, Lacroix L, Attard M, Grimaldi S, Corre R, Ricard M, Nasr S, Berdelou A, Hadoux J, Hartl D, Terroir M, Baudin E, Schlumberger M, Al Ghuzlan A.

Thyroid. 2019 May;29(5):735-742. doi: 10.1089/thy.2018.0457.

PMID:
30880598
18.

A Highly Accurate Pixel-Based FRAP Model Based on Spectral-Domain Numerical Methods.

Röding M, Lacroix L, Krona A, Gebäck T, Lorén N.

Biophys J. 2019 Apr 2;116(7):1348-1361. doi: 10.1016/j.bpj.2019.02.023. Epub 2019 Mar 1.

19.

Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR.

Madic J, Jovelet C, Lopez J, André B, Fatien J, Miran I, Honoré A, Mezquita L, Besse B, Lacroix L, Droniou M.

Oncotarget. 2019 Feb 12;10(13):1345. doi: 10.18632/oncotarget.26686. eCollection 2019 Feb 12.

20.

Revisiting immune escape in colorectal cancer in the era of immunotherapy.

Ijsselsteijn ME, Petitprez F, Lacroix L, Ruano D, van der Breggen R, Julie C, Morreau H, Sautès-Fridman C, Fridman WH, de Miranda NFDCC.

Br J Cancer. 2019 Apr;120(8):815-818. doi: 10.1038/s41416-019-0421-x. Epub 2019 Mar 13.

21.

To heat or not to heat: a study of the performances of iron carbide nanoparticles in magnetic heating.

Asensio JM, Marbaix J, Mille N, Lacroix LM, Soulantica K, Fazzini PF, Carrey J, Chaudret B.

Nanoscale. 2019 Mar 21;11(12):5402-5411. doi: 10.1039/c8nr10235j.

PMID:
30854537
22.

A mobile device application to reduce medication errors and time to drug delivery during simulated paediatric cardiopulmonary resuscitation: a multicentre, randomised, controlled, crossover trial.

Siebert JN, Ehrler F, Combescure C, Lovis C, Haddad K, Hugon F, Luterbacher F, Lacroix L, Gervaix A, Manzano S; PedAMINES Trial Group.

Lancet Child Adolesc Health. 2019 May;3(5):303-311. doi: 10.1016/S2352-4642(19)30003-3. Epub 2019 Feb 21.

PMID:
30797722
23.

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR.

Madic J, Jovelet C, Lopez J, André B, Fatien J, Miran I, Honoré A, Mezquita L, Besse B, Lacroix L, Droniou M.

Oncotarget. 2018 Dec 21;9(100):37393-37406. doi: 10.18632/oncotarget.26446. eCollection 2018 Dec 21. Erratum in: Oncotarget. 2019 Feb 12;10(13):1345. Lezquita, Laura [corrected to Mezquita, Laura].

24.

Chemical Ordering in Bimetallic FeCo Nanoparticles: From a Direct Chemical Synthesis to Application As Efficient High-Frequency Magnetic Material.

Garnero C, Lepesant M, Garcia-Marcelot C, Shin Y, Meny C, Farger P, Warot-Fonrose B, Arenal R, Viau G, Soulantica K, Fau P, Poveda P, Lacroix LM, Chaudret B.

Nano Lett. 2019 Feb 13;19(2):1379-1386. doi: 10.1021/acs.nanolett.8b05083. Epub 2019 Jan 25.

PMID:
30645938
25.

Impregnation of High-Magnetization FeCo Nanoparticles in Mesoporous Silicon: An Experimental Approach.

Lepesant M, Bardet B, Lacroix LM, Fau P, Garnero C, Chaudret B, Soulantica K, Defforge T, Valente D, Andreazza C, Billoué J, Poveda P, Gautier G.

Front Chem. 2018 Dec 18;6:609. doi: 10.3389/fchem.2018.00609. eCollection 2018.

26.

Shape selection through epitaxy of supported platinum nanocrystals.

Peres L, Yi D, Bustos-Rodriguez S, Marcelot C, Pierrot A, Fazzini PF, Florea I, Arenal R, Lacroix LM, Warot-Fonrose B, Blon T, Soulantica K.

Nanoscale. 2018 Dec 13;10(48):22730-22736. doi: 10.1039/c8nr07515h.

PMID:
30500037
27.

Rare and striking complication of Henoch-Schönlein purpura.

Moussaoui D, Barasche J, Lacroix L.

Arch Dis Child. 2018 Nov 23. pii: archdischild-2018-316134. doi: 10.1136/archdischild-2018-316134. [Epub ahead of print] No abstract available.

PMID:
30470683
28.

G4HunterApps.

Lacroix L.

Bioinformatics. 2019 Jul 1;35(13):2311-2312. doi: 10.1093/bioinformatics/bty951.

29.

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine.

Petitprez F, Sun CM, Lacroix L, Sautès-Fridman C, de Reyniès A, Fridman WH.

Front Oncol. 2018 Sep 25;8:390. doi: 10.3389/fonc.2018.00390. eCollection 2018. Review.

30.

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Weinstein AM, Giraldo NA, Petitprez F, Julie C, Lacroix L, Peschaud F, Emile JF, Marisa L, Fridman WH, Storkus WJ, Sautès-Fridman C.

Cancer Immunol Immunother. 2019 Jan;68(1):109-120. doi: 10.1007/s00262-018-2259-0. Epub 2018 Oct 12.

PMID:
30315348
31.

Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?

Prud'homme C, Deschamps F, Allorant A, Massard C, Hollebecque A, Yevich S, Ngo-Camus M, Gravel G, Nicotra C, Michiels S, Scoazec JY, Lacroix L, Solary E, Soria JC, De Baere T, Tselikas L.

Eur J Cancer. 2018 Nov;103:108-119. doi: 10.1016/j.ejca.2018.08.003. Epub 2018 Sep 14.

PMID:
30223224
32.

Ultrathin Gold Nanowires with the Polytetrahedral Structure of Bulk Manganese.

Vargas JA, Petkov V, Nouh ESA, Ramamoorthy RK, Lacroix LM, Poteau R, Viau G, Lecante P, Arenal R.

ACS Nano. 2018 Sep 25;12(9):9521-9531. doi: 10.1021/acsnano.8b05036. Epub 2018 Sep 14.

PMID:
30199625
33.

Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid EGFR/KRAS analysis in 43 cases.

Ghigna MR, Crutu A, Florea V, Feuillet-Soummer S, Baldeyrou P, Adam J, Lacroix L, Besse B, Mercier O, Fadel E, Dorfmuller P, El Ayoubi R, Thomas de Montpréville V.

J Thorac Dis. 2018 Jul;10(7):4653-4658. doi: 10.21037/jtd.2018.06.157.

34.

Synergism of Au and Ru Nanoparticles in Low-Temperature Photoassisted CO2 Methanation.

Mateo D, De Masi D, Albero J, Lacroix LM, Fazzini PF, Chaudret B, García H.

Chemistry. 2018 Dec 10;24(69):18436-18443. doi: 10.1002/chem.201803022. Epub 2018 Oct 12.

35.

Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.

Koeppel F, Bobard A, Lefebvre C, Pedrero M, Deloger M, Boursin Y, Richon C, Chen-Min-Tao R, Robert G, Meurice G, Rouleau E, Michiels S, Massard C, Scoazec JY, Solary E, Soria JC, André F, Lacroix L.

Cancer J. 2018 Jul/Aug;24(4):153-162. doi: 10.1097/PPO.0000000000000322. Review.

PMID:
30119077
36.

Three-Dimensional Branched and Faceted Gold-Ruthenium Nanoparticles: Using Nanostructure to Improve Stability in Oxygen Evolution Electrocatalysis.

Gloag L, Benedetti TM, Cheong S, Li Y, Chan XH, Lacroix LM, Chang SLY, Arenal R, Florea I, Barron H, Barnard AS, Henning AM, Zhao C, Schuhmann W, Gooding JJ, Tilley RD.

Angew Chem Int Ed Engl. 2018 Aug 6;57(32):10241-10245. doi: 10.1002/anie.201806300. Epub 2018 Jul 15.

PMID:
29896878
37.

Quadruplexes in 'Dicty': crystal structure of a four-quartet G-quadruplex formed by G-rich motif found in the Dictyostelium discoideum genome.

Guédin A, Lin LY, Armane S, Lacroix L, Mergny JL, Thore S, Yatsunyk LA.

Nucleic Acids Res. 2018 Jun 1;46(10):5297-5307. doi: 10.1093/nar/gky290.

38.

First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma.

Lehmann-Che J, Miquel C, Wong J, Callens C, Rouleau E, Quillien V, Lozano N, Cayre A, Lacroix L, Bieche I, Bertheau P, Teixeira L, Llorca FP, Lamy PJ, DE Cremoux P; GFCO GROUP.

Anticancer Res. 2018 May;38(5):2909-2914.

PMID:
29715116
39.

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.

Mahjoubi L, Cecchi F, Massard C, Calabro F, Gazzah A, Bahleda R, Jamme P, Gelli M, Goere D, Lacroix L, Adam J, Heukamp L, Trenta P, Hembrough T, Soria JC, Sternberg C, Ducreux M.

Tumori. 2018 Dec;104(6):NP38-NP41. doi: 10.1177/0300891618763215. Epub 2018 Mar 21.

PMID:
29714649
40.

Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?

Mirghani H, Lacroix L, Rossoni C, Sun R, Aupérin A, Casiraghi O, Villepelet A, Lacave R, Faucher G, Marty V, Ferté C, Soria JC, Even C.

Eur J Cancer. 2018 May;94:61-69. doi: 10.1016/j.ejca.2018.02.013. Epub 2018 Mar 20.

PMID:
29533868
41.

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.

Cabel L, Fuerea A, Lacroix L, Baldini C, Martin P, Hollebecque A, Postel-Vinay S, Varga A, Balheda R, Gazzah A, Michot JM, Marabelle A, Rouleau E, Solary E, De Baere T, Angevin E, Armand JP, Michiels S, Scoazec JY, Ammari S, André F, Soria JC, Massard C, Verlingue L.

Oncotarget. 2018 Jan 12;9(11):9741-9750. doi: 10.18632/oncotarget.24188. eCollection 2018 Feb 9.

42.

Corrigendum to "Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial" [Eur J Cancer 87 (2017) 122-130].

Verlingue L, Malka D, Allorant A, Massard C, Ferté C, Lacroix L, Rouleau E, Auger N, Ngo M, Nicotra C, De Baere T, Tselikas L, Ba B, Michiels S, Scoazec JY, Boige V, Ducreux M, Soria JC, Hollebecque A.

Eur J Cancer. 2018 Apr;93:156-157. doi: 10.1016/j.ejca.2018.01.077. Epub 2018 Feb 14. No abstract available.

PMID:
29454743
43.

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door.

Verlingue L, Hollebecque A, Lacroix L, Postel-Vinay S, Varga A, El Dakdouki Y, Baldini C, Balheda R, Gazzah A, Michot JM, Marabelle A, Mir O, Arnedos M, Rouleau E, Solary E, De Baere T, Angevin E, Armand JP, Michiels S, André F, Deutsch E, Scoazec JY, Soria JC, Massard C.

Eur J Cancer. 2018 Mar;92:1-10. doi: 10.1016/j.ejca.2017.12.020. Epub 2018 Feb 3.

PMID:
29413684
44.

Refined Lab-score, a Risk Score Predicting Serious Bacterial Infection in Febrile Children Less Than 3 Years of Age.

Leroy S, Bressan S, Lacroix L, Andreola B, Zamora S, Bailey B, Da Dalt L, Manzano S, Gervaix A, Galetto-Lacour A.

Pediatr Infect Dis J. 2018 May;37(5):387-393. doi: 10.1097/INF.0000000000001915.

PMID:
29373477
45.

Accessory Spleen Fracture: Report of a Pediatric Case and Review of the Literature.

Chauvet E, Spyropoulou V, Anooshiravani-Dumont M, Sanchez O, Lacroix L.

Pediatr Emerg Care. 2020 Jan;36(1):e10-e13. doi: 10.1097/PEC.0000000000001381.

PMID:
29298250
46.

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.

Delahousse J, Verlingue L, Broutin S, Legoupil C, Touat M, Doucet L, Ammari S, Lacroix L, Ducreux M, Scoazec JY, Malka D, Paci A, Hollebecque A.

Eur J Cancer. 2018 Feb;90:83-91. doi: 10.1016/j.ejca.2017.11.024. Epub 2018 Jan 4.

PMID:
29274619
47.

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.

Condorelli R, Spring L, O'Shaughnessy J, Lacroix L, Bailleux C, Scott V, Dubois J, Nagy RJ, Lanman RB, Iafrate AJ, Andre F, Bardia A.

Ann Oncol. 2018 Mar 1;29(3):640-645. doi: 10.1093/annonc/mdx784.

48.

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.

Facchinetti F, Bluthgen MV, Tergemina-Clain G, Faivre L, Pignon JP, Planchard D, Remon J, Soria JC, Lacroix L, Besse B.

Lung Cancer. 2017 Oct;112:62-68. doi: 10.1016/j.lungcan.2017.08.002. Epub 2017 Aug 7.

PMID:
29191602
49.

Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.

Koeppel F, Blanchard S, Jovelet C, Genin B, Marcaillou C, Martin E, Rouleau E, Solary E, Soria JC, André F, Lacroix L.

PLoS One. 2017 Nov 21;12(11):e0188174. doi: 10.1371/journal.pone.0188174. eCollection 2017.

50.

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.

Verlingue L, Malka D, Allorant A, Massard C, Ferté C, Lacroix L, Rouleau E, Auger N, Ngo M, Nicotra C, De Baere T, Tselikas L, Ba B, Michiels S, Scoazec JY, Boige V, Ducreux M, Soria JC, Hollebecque A.

Eur J Cancer. 2017 Dec;87:122-130. doi: 10.1016/j.ejca.2017.10.013. Epub 2017 Nov 14. Erratum in: Eur J Cancer. 2018 Feb 14;:.

PMID:
29145038

Supplemental Content

Loading ...
Support Center